Clinical Project Manager - (Oncology & Inflammatory) at Gilead Sciences

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Therapeutic area expertise in Oncology & Inflammatory diseases
Ability to establish and maintain relationships with investigator sites and Gilead’s preferred network of sites
Expertise in site identification, qualification, enrollment planning, and execution
Knowledge of clinical trial processes from study start-up to closeout, including database lock and study close out
Ability to track key performance metrics and assess site performance
Technical expertise for scientific discussions with investigators and site personnel
Understanding of competitive landscape, patient treatment pathways, and operational considerations impacting clinical trials
Experience working with study teams and Clinical Research Organizations (CROs)
Hybrid work capability based in Warsaw, Poland
Willingness to take on additional local responsibilities as needed for the geography

Responsibilities

Establish and maintain strong professional and collaborative relationships with investigator sites by leveraging disease area expertise to optimize delivery of clinical trial programs
Develop strategies to drive concierge level support for preferred sites to ensure Gilead becomes the Sponsor of Choice
Track key performance metrics to assess site performance and identify opportunities for acceleration and continuous improvement
Identify investigator sites in alignment with portfolio strategy and priority to expand Gilead’s clinical research partnership network
Maintain therapeutic and technical expertise to enable scientific discussions with the investigator and site personnel
Share ongoing information with investigators regarding Gilead's development pipeline and collect and report field-based intelligence in relation to competitive landscape, patient treatment pathways and other operational considerations that may impact Gilead's clinical trial program
Provide support to study teams and Clinical Research Organizations (CROs) to ensure timely delivery of clinical trials from study start-up to closeout such as during feasibility, site recommendations, attendance at initiation visits, facilitation of communication and ongoing support of trial enrollment by engaging with site staff to identify enrollment barriers and working with study teams to find solutions
Gather constructive feedback and insights from sites

Skills

Clinical Trials

Site Management

Investigator Relations

Enrollment Planning

Study Closeout

Oncology

Inflammatory Diseases

Phase I-IV

SOPs

Regulatory Guidelines

Database Lock

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free